Global Early Detection of Multiple Cancers Market Research Report 2024

Publication ID:

PB509241542

Publication Date:

September 2, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Early Detection of Multiple Cancers is a diagnosis and treatment method specifically for early-stage cancer patients, with the purpose of early detection and early treatment, so as to reduce the pain, mental and economic burden of patients. Strive for early recovery of cancer patients through early diagnosis and treatment of cancer.
The global Early Detection of Multiple Cancers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Early Detection of Multiple Cancers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Early Detection of Multiple Cancers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Early Detection of Multiple Cancers in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Early Detection of Multiple Cancers include Grail, Exact Sciences, Foundation Medicine, AnchorDx, Guardant Health, Burning Rock Biotech, GENECAST, Labporatory for Advanced Medicine and Health Group and Singlera Genomics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Early Detection of Multiple Cancers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Early Detection of Multiple Cancers.
Report Scope
The Early Detection of Multiple Cancers market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Early Detection of Multiple Cancers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Early Detection of Multiple Cancers companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Grail
Exact Sciences
Foundation Medicine
AnchorDx
Guardant Health
Burning Rock Biotech
GENECAST
Labporatory for Advanced Medicine and Health Group
Singlera Genomics
Johns Hopkins Medicine
Bioscience
Genetron Holdings
Shenzhen Ruisi
Shanghai Majorbio Bio-Pharm Technology
Shanghai Gurong
Segment by Type
Liquid Biopsy
Gene Panel
Others
Segment by Application
Hospitals
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Early Detection of Multiple Cancers companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Early Detection of Multiple Cancers Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Liquid Biopsy
1.2.3 Gene Panel
1.2.4 Others
1.3 Market by Application
1.3.1 Global Early Detection of Multiple Cancers Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Early Detection of Multiple Cancers Market Perspective (2019-2030)
2.2 Early Detection of Multiple Cancers Growth Trends by Region
2.2.1 Global Early Detection of Multiple Cancers Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Early Detection of Multiple Cancers Historic Market Size by Region (2019-2024)
2.2.3 Early Detection of Multiple Cancers Forecasted Market Size by Region (2025-2030)
2.3 Early Detection of Multiple Cancers Market Dynamics
2.3.1 Early Detection of Multiple Cancers Industry Trends
2.3.2 Early Detection of Multiple Cancers Market Drivers
2.3.3 Early Detection of Multiple Cancers Market Challenges
2.3.4 Early Detection of Multiple Cancers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Early Detection of Multiple Cancers Players by Revenue
3.1.1 Global Top Early Detection of Multiple Cancers Players by Revenue (2019-2024)
3.1.2 Global Early Detection of Multiple Cancers Revenue Market Share by Players (2019-2024)
3.2 Global Early Detection of Multiple Cancers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Early Detection of Multiple Cancers Revenue
3.4 Global Early Detection of Multiple Cancers Market Concentration Ratio
3.4.1 Global Early Detection of Multiple Cancers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Early Detection of Multiple Cancers Revenue in 2023
3.5 Early Detection of Multiple Cancers Key Players Head office and Area Served
3.6 Key Players Early Detection of Multiple Cancers Product Solution and Service
3.7 Date of Enter into Early Detection of Multiple Cancers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Early Detection of Multiple Cancers Breakdown Data by Type
4.1 Global Early Detection of Multiple Cancers Historic Market Size by Type (2019-2024)
4.2 Global Early Detection of Multiple Cancers Forecasted Market Size by Type (2025-2030)
5 Early Detection of Multiple Cancers Breakdown Data by Application
5.1 Global Early Detection of Multiple Cancers Historic Market Size by Application (2019-2024)
5.2 Global Early Detection of Multiple Cancers Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Early Detection of Multiple Cancers Market Size (2019-2030)
6.2 North America Early Detection of Multiple Cancers Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Early Detection of Multiple Cancers Market Size by Country (2019-2024)
6.4 North America Early Detection of Multiple Cancers Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Early Detection of Multiple Cancers Market Size (2019-2030)
7.2 Europe Early Detection of Multiple Cancers Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Early Detection of Multiple Cancers Market Size by Country (2019-2024)
7.4 Europe Early Detection of Multiple Cancers Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Early Detection of Multiple Cancers Market Size (2019-2030)
8.2 Asia-Pacific Early Detection of Multiple Cancers Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Early Detection of Multiple Cancers Market Size by Region (2019-2024)
8.4 Asia-Pacific Early Detection of Multiple Cancers Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Early Detection of Multiple Cancers Market Size (2019-2030)
9.2 Latin America Early Detection of Multiple Cancers Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Early Detection of Multiple Cancers Market Size by Country (2019-2024)
9.4 Latin America Early Detection of Multiple Cancers Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Early Detection of Multiple Cancers Market Size (2019-2030)
10.2 Middle East & Africa Early Detection of Multiple Cancers Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Early Detection of Multiple Cancers Market Size by Country (2019-2024)
10.4 Middle East & Africa Early Detection of Multiple Cancers Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grail
11.1.1 Grail Company Detail
11.1.2 Grail Business Overview
11.1.3 Grail Early Detection of Multiple Cancers Introduction
11.1.4 Grail Revenue in Early Detection of Multiple Cancers Business (2019-2024)
11.1.5 Grail Recent Development
11.2 Exact Sciences
11.2.1 Exact Sciences Company Detail
11.2.2 Exact Sciences Business Overview
11.2.3 Exact Sciences Early Detection of Multiple Cancers Introduction
11.2.4 Exact Sciences Revenue in Early Detection of Multiple Cancers Business (2019-2024)
11.2.5 Exact Sciences Recent Development
11.3 Foundation Medicine
11.3.1 Foundation Medicine Company Detail
11.3.2 Foundation Medicine Business Overview
11.3.3 Foundation Medicine Early Detection of Multiple Cancers Introduction
11.3.4 Foundation Medicine Revenue in Early Detection of Multiple Cancers Business (2019-2024)
11.3.5 Foundation Medicine Recent Development
11.4 AnchorDx
11.4.1 AnchorDx Company Detail
11.4.2 AnchorDx Business Overview
11.4.3 AnchorDx Early Detection of Multiple Cancers Introduction
11.4.4 AnchorDx Revenue in Early Detection of Multiple Cancers Business (2019-2024)
11.4.5 AnchorDx Recent Development
11.5 Guardant Health
11.5.1 Guardant Health Company Detail
11.5.2 Guardant Health Business Overview
11.5.3 Guardant Health Early Detection of Multiple Cancers Introduction
11.5.4 Guardant Health Revenue in Early Detection of Multiple Cancers Business (2019-2024)
11.5.5 Guardant Health Recent Development
11.6 Burning Rock Biotech
11.6.1 Burning Rock Biotech Company Detail
11.6.2 Burning Rock Biotech Business Overview
11.6.3 Burning Rock Biotech Early Detection of Multiple Cancers Introduction
11.6.4 Burning Rock Biotech Revenue in Early Detection of Multiple Cancers Business (2019-2024)
11.6.5 Burning Rock Biotech Recent Development
11.7 GENECAST
11.7.1 GENECAST Company Detail
11.7.2 GENECAST Business Overview
11.7.3 GENECAST Early Detection of Multiple Cancers Introduction
11.7.4 GENECAST Revenue in Early Detection of Multiple Cancers Business (2019-2024)
11.7.5 GENECAST Recent Development
11.8 Labporatory for Advanced Medicine and Health Group
11.8.1 Labporatory for Advanced Medicine and Health Group Company Detail
11.8.2 Labporatory for Advanced Medicine and Health Group Business Overview
11.8.3 Labporatory for Advanced Medicine and Health Group Early Detection of Multiple Cancers Introduction
11.8.4 Labporatory for Advanced Medicine and Health Group Revenue in Early Detection of Multiple Cancers Business (2019-2024)
11.8.5 Labporatory for Advanced Medicine and Health Group Recent Development
11.9 Singlera Genomics
11.9.1 Singlera Genomics Company Detail
11.9.2 Singlera Genomics Business Overview
11.9.3 Singlera Genomics Early Detection of Multiple Cancers Introduction
11.9.4 Singlera Genomics Revenue in Early Detection of Multiple Cancers Business (2019-2024)
11.9.5 Singlera Genomics Recent Development
11.10 Johns Hopkins Medicine
11.10.1 Johns Hopkins Medicine Company Detail
11.10.2 Johns Hopkins Medicine Business Overview
11.10.3 Johns Hopkins Medicine Early Detection of Multiple Cancers Introduction
11.10.4 Johns Hopkins Medicine Revenue in Early Detection of Multiple Cancers Business (2019-2024)
11.10.5 Johns Hopkins Medicine Recent Development
11.11 Bioscience
11.11.1 Bioscience Company Detail
11.11.2 Bioscience Business Overview
11.11.3 Bioscience Early Detection of Multiple Cancers Introduction
11.11.4 Bioscience Revenue in Early Detection of Multiple Cancers Business (2019-2024)
11.11.5 Bioscience Recent Development
11.12 Genetron Holdings
11.12.1 Genetron Holdings Company Detail
11.12.2 Genetron Holdings Business Overview
11.12.3 Genetron Holdings Early Detection of Multiple Cancers Introduction
11.12.4 Genetron Holdings Revenue in Early Detection of Multiple Cancers Business (2019-2024)
11.12.5 Genetron Holdings Recent Development
11.13 Shenzhen Ruisi
11.13.1 Shenzhen Ruisi Company Detail
11.13.2 Shenzhen Ruisi Business Overview
11.13.3 Shenzhen Ruisi Early Detection of Multiple Cancers Introduction
11.13.4 Shenzhen Ruisi Revenue in Early Detection of Multiple Cancers Business (2019-2024)
11.13.5 Shenzhen Ruisi Recent Development
11.14 Shanghai Majorbio Bio-Pharm Technology
11.14.1 Shanghai Majorbio Bio-Pharm Technology Company Detail
11.14.2 Shanghai Majorbio Bio-Pharm Technology Business Overview
11.14.3 Shanghai Majorbio Bio-Pharm Technology Early Detection of Multiple Cancers Introduction
11.14.4 Shanghai Majorbio Bio-Pharm Technology Revenue in Early Detection of Multiple Cancers Business (2019-2024)
11.14.5 Shanghai Majorbio Bio-Pharm Technology Recent Development
11.15 Shanghai Gurong
11.15.1 Shanghai Gurong Company Detail
11.15.2 Shanghai Gurong Business Overview
11.15.3 Shanghai Gurong Early Detection of Multiple Cancers Introduction
11.15.4 Shanghai Gurong Revenue in Early Detection of Multiple Cancers Business (2019-2024)
11.15.5 Shanghai Gurong Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Grail
Exact Sciences
Foundation Medicine
AnchorDx
Guardant Health
Burning Rock Biotech
GENECAST
Labporatory for Advanced Medicine and Health Group
Singlera Genomics
Johns Hopkins Medicine
Bioscience
Genetron Holdings
Shenzhen Ruisi
Shanghai Majorbio Bio-Pharm Technology
Shanghai Gurong

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂